Dr. Iruela-Arispe on the Dr. Paul Janssen Award Symposium

Dr. Luisa Iruela-Arispe from University of California, Los Angeles on the Dr. Paul Janssen Award Symposium

Luisa Iruela-Arispe, PhD, director, JCCC Cancer and Stem Cell Biology Program Area, professor and vice chair, Molecular, Cell, and Developmental Biology, University of California, Los Angeles (UCLA), discusses the highlights from the 2011 Dr. Paul Janssen Award Symposium, Wednesday, September 14, 2011, in New York City, NY.

The symposium highlighted the benefits of single agent bevacizumab (Avastin) and awarded the 2011 Dr. Paul Janssen Award for Biomedical Research to Napoleone Ferrara, MD, the discoverer of the vascular endothelial growth factor (VEGF) angiogenic-signaling molecule.

Angiogenesis breakthroughs and therapeutic applications were the focus of the one-day symposium; it focused specifically on bevacizumab and its impact on multiple individual lives. The need to work across multiple disciplines to enhance the drugs efficacy and possible combinations with other targeted therapeutics was the main topic of discussion.

Related Videos
Karl Semaan, MD, MSc
Bradley McGregor, MD, discusses findings from a phase 1b study of abemaciclib  in clear cell renal cell carcinoma.
Marc-Oliver Grimm, MD
Chun Chao, PhD, MS
Mikkael A. Sekeres, MD
Noa Biran, MD
Ranee Mehra, MD, professor, medicine, medical oncology; director, Head and Neck Medical Oncology, Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Medical System
Sumanta Kumar Pal, MD, FASCO, chair, Kidney and Bladder Cancer Disease Team; co-director, Kidney Cancer Program; professor, vice chair, Academic Affairs, Department of Medical Oncology & Therapeutics Research, City of Hope
Alfred L. Garfall, MD, MS
David Braun, MD, PhD